For the first time, genetically engineered tomato plants produced
a peptide that mimics the actions of good cholesterol when eaten, researchers
reported at the American Heart Association's Scientific Sessions 2012.
In the study, mice that ate the freeze-dried, ground tomatoes had less
inflammation and reduced atherosclerosis (plaque build-up in the arteries).
"We have found a new and practical way to make a peptide that
acts like the main protein in good cholesterol, but is many times more
effective and can be delivered by eating the plant," said Alan M.
Fogelman, M.D., senior author of the study and executive chair of the
Department of Medicine and director of the Atherosclerosis Research Unit in the
David Geffen School of Medicine at UCLA.
Researchers genetically engineered the tomatoes to produce 6F, a
small peptide that mimics the action of ApoA-1, the chief protein in high
density lipoprotein (HDL or "good" cholesterol). They fed the
tomatoes to mice that lack the ability to remove low density lipoprotein (LDL
or "bad" cholesterol) from their blood and readily develop
inflammation and atherosclerosis when consuming a high-fat diet.
After the mice ate the tomatoes as 2.2 percent of their
Western-style high-fat, calorie-packed diet, those given the peptide-enhanced
tomatoes had significantly:
·
lower blood levels of
inflammation;
·
higher paraoxonase
activity, an anti-oxidant enzyme associated with good cholesterol and related
to a lower risk of heart disease;
·
higher levels of good
cholesterol;
·
decreased
lysophosphatidic acid, a tumor promoter that accelerates plaque build-up in
arteries in animal models; and
·
less atherosclerotic
plaque.
"To our knowledge this is the first example of a drug with
these properties that has been produced in an edible plant and is biologically
active when fed without any isolation or purification of the drug,"
Fogelman said.
Co-authors are Arnab Chattopadhyay, Ph.D.; Mohamad Navab, Ph.D.;
Greg Hough, B.S.; David Meriwether, B.S.; Gao Feng, Ph.D.; Victor Grijalva,
B.S.; James R. Springstead, Ph.D.; Mayakonda N. Palgunachari, Ph.D.; Ryan
Namiri-Kalantari, B.S.; G.M. Anantharamaya, Ph.D.; Robin Farias-Eisner, M.D.,
Ph.D.; and Srinivasa T. Reddy, Ph.D. Author disclosures are on the abstract.
0 comments:
Post a Comment